What are key trends in the transparency compliance landscape? And, how are life sciences manufacturers tackling growing requirements

The pharma industry’s R&D concentration has been shifting towards specialty therapy areas as research and development returns decline for some leaders.

The CHC’s mission is to promote and protect the benefit, for society and individual patient care, of the free flow of healthcare information.

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, […]

What are key trends in the transparency compliance landscape?

For the eighth year, Med Ad News has chosen three Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.

Merck and Pfizer collaborate with Dako in developing an immunohistochemistry (IHC)-based companion diagnostic (CDx) in immuno-oncology     September 24, 2015 05:00 PM Eastern Daylight Time   DARMSTADT, Germany & […]

Closely held Intarcia Therapeutics Inc. said its implantable drug-delivery pump proved superior to Merck MRK -0.42 % & Co.’s top-selling drug Januvia in helping diabetes patients control blood sugar in […]

Electronic cigarettes are less harmful than smoking traditional cigarettes and can be effective tools to help smokers quit, according to a review published Wednesday by Public Health England, a government […]

DANVERS, Mass.–(BUSINESS WIRE)–NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd, announced that the Samsung GC85A Digital Radiography (DR) system has received 510(k) FDA clearance, paving the way for its availability […]